Dataset Information


Activity of ADAM17 (a disintegrin and metalloprotease 17) is regulated by its noncatalytic domains and secondary structure of its substrates.

ABSTRACT: ADAM proteases are implicated in multiple diseases, but no drugs based on ADAM inhibition exist. Most of the ADAM inhibitors developed to date feature zinc-binding moieties that target the active site zinc, which leads to a lack of selectivity and off target toxicity. Targeting secondary substrate binding sites (exosites) can potentially work as an alternative strategy for drug discovery; however, there are only a few reports of potential exosites in ADAM protease structures. In the study presented here, we utilized a series of TNF?-based substrates to probe ADAM10 and 17 interactions with its canonical substrate to identify the structural features that determine ADAM protease substrate specificity. We found that noncatalytic domains of ADAM17 did not directly bind the substrates used in the study but affected the binding nevertheless, most likely because of steric hindrance. Additionally, noncatalytic domains of ADAM17 affected the size/shape of the carbohydrate-binding pocket contained within the catalytic domain of ADAM17. This suggests that noncatalytic domains of ADAM17 play a role in substrate specificity and might help explain differences in substrate repertoires of ADAM17 and its closest homologue, ADAM10. We also addressed the question of which substrate features can affect ADAM protease specificity. We found that all ADAM proteases tested (i.e., ADAM10, 12, and 17) significantly decreased activity when the TNF?-derived sequence was induced into ?-helical conformation, suggesting that conformation plays a role in determining ADAM protease substrate specificity. These findings can help in the discovery of ADAM isoform- and substrate-specific inhibitors.

SUBMITTER: Stawikowska R 

PROVIDER: S-EPMC3829370 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC3476313 | BioStudies
2016-01-01 | S-EPMC5431342 | BioStudies
2015-01-01 | S-EPMC5420329 | BioStudies
2016-01-01 | S-EPMC4865905 | BioStudies
2011-01-01 | S-EPMC3083187 | BioStudies
2014-01-01 | S-EPMC4036340 | BioStudies
1000-01-01 | S-EPMC4196152 | BioStudies
2015-01-01 | S-EPMC4561721 | BioStudies
2014-01-01 | S-EPMC3922520 | BioStudies
2020-01-01 | S-EPMC7517301 | BioStudies